Wall Street ends higher as investors bet on positive earnings season



(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)

By Shreyashi Sanyal and Sinéad Carew

Oct 19 (Reuters) - U.S. stock indexes closed higher on Tuesday with the biggest boosts from the technology and healthcare sectors as investors appeared to bet on solid quarterly reports even as some worried that it was too early to celebrate.

In its fifth straight session of gains, the benchmark S&P 500 index .SPX finished just 0.4% below its early September record close while the Dow Jones Industrials average .DJI ended the day about 0.5% below its record reached in mid-August.

Johnson & Johnson's JNJ.N shares added 2.3% providing a big boost to the S&P 500 after it raised its 2021 adjusted profit forecast. Insurer Travelers Cos Inc TRV.N climbed 1.6% after beating its profit estimates.

High-profile technology and communications companies were also big S&P boosts with Apple Inc AAPL.O , Facebook FB.O and Microsoft MSFT.O all rising.

But in the second week of earnings with a "very small sample" of releases, Steve Sosnick, chief strategist at Interactive Brokers, worried about a possible pullback.

"We're seeing volatility measures like the VIX flipping from nervous to complacent in a really short period of time," said Sosnick. "We may be a bit ahead of ourselves. The mostly likely scenario is that we make one more run at new S&P highs and then we pull back, subject to earnings."

The CBOE market volatility index .VIX fell 0.6 points after earlier hitting 15.57, its lowest level since mid-August.

Analysts now expect S&P 500 earnings to rise 32.4% from a year earlier, according to Refinitiv data.

"The key for the market to going up from here will not be higher multiples, it will have to be higher earnings. That's why it's so important to pay attention to what those profit margins do going forward and what the trajectory of GDP looks like," said Eric Marshall, portfolio manager at Hodges Funds.

"Investors will be paying very close attention to pricing power, how companies are dealing with labor shortages and inflationary cost pressures within their business."

The Dow Jones Industrial Average .DJI rose 198.7 points, or 0.56%, to 35,457.31, the S&P 500 .SPX gained 33.17 points, or 0.74%, to 4,519.63 and the Nasdaq Composite .IXIC added 107.28 points, or 0.71%, to 15,129.09.

Ten of the eleven major S&P 500 sectors closed higher, with healthcare stocks .SPXHC , up 1.3% after dropping 0.7% in Monday's session. The next biggest gainer was utilities .SPLRCU , which rose 1.26% after falling almost 1% Monday.

Netflix Inc NFLX.O , after closing up 0.2%, added slightly to gains after the bell when quarterly results showed that global interest in Korean thriller "Squid Game" lured more new customers than expected.

Tesla Inc TSLA.O , which closed down 0.7%, is due to release results on Wednesday, with investors watching for indications of its performance in China.

Procter & Gamble Co PG.N , fell 1% during the session, after it warned that it would have to raise prices of some products to counter higher commodity and freight costs.

However, Walmart Inc WMT.N shares added 2% after being added to Goldman Sachs "Americas Conviction List."

Helping the healthcare sector on Tuesday was drugmaker Merck & Co Inc MRK.N , which rose 3% while Pfizer Inc PFE.N climbed 1.9% following the release of a competitor's COVID-19 drug study results.

Its competitor, Atea Pharmaceuticals Inc AVIR.O , fell 66% after the company's antiviral pill, being developed with Roche ROG.S , failed to help patients with mild and moderate COVID-19.

Advancing issues outnumbered declining ones on the NYSE by a 1.51-to-1 ratio; on Nasdaq, a 1.69-to-1 ratio favored advancers.

The S&P 500 posted 44 new 52-week highs and 1 new lows; the Nasdaq Composite recorded 72 new highs and 69 new lows.

On U.S. exchanges 9.5 billion shares changed hands compared with the 10.29 billion moving average for the last 20 sessions.
Reporting by Shreyashi Sanyal and Devik Jain in Bengaluru; Sinéad Carew in New York, Editing by Saumyadeb Chakrabarty, Shounak Dasgupta and Aurora Ellis

Ansvarsfriskrivning: XM Group-enheter tillhandahåller sin tjänst enbart för exekvering och tillgången till vår onlinehandelsplattform, som innebär att en person kan se och/eller använda tillgängligt innehåll på eller via webbplatsen, påverkar eller utökar inte detta, vilket inte heller varit avsikten. Denna tillgång och användning omfattas alltid av i) villkor, ii) riskvarningar och iii) fullständig ansvarsfriskrivning. Detta innehåll tillhandahålls därför uteslutande som allmän information. Var framför allt medveten om att innehållet på vår onlinehandelsplattform varken utgör en uppmaning eller ett erbjudande om att ingå några transaktioner på de finansiella marknaderna. Handel på alla finansiella marknader involverar en betydande risk för ditt kapital.

Allt material som publiceras på denna sida är enbart avsett för utbildnings- eller informationssyften och innehåller inte – och ska inte heller anses innehålla – rådgivning och rekommendationer om finansiella frågor, investeringsskatt eller handel, dokumentation av våra handelskurser eller ett erbjudande om, eller en uppmaning till, en transaktion i finansiella instrument eller oönskade finansiella erbjudanden som är riktade till dig.

Tredjepartsinnehåll, liksom innehåll framtaget av XM såsom synpunkter, nyheter, forskningsrön, analyser, kurser, andra uppgifter eller länkar till tredjepartssajter som återfinns på denna webbplats, tillhandahålls i befintligt skick, som allmän marknadskommentar, och utgör ingen investeringsrådgivning. I den mån som något innehåll tolkas som investeringsforskning måste det noteras och accepteras att innehållet varken har varit avsett som oberoende investeringsforskning eller har utarbetats i enlighet med de rättsliga kraven för att främja ett sådant syfte, och därför är att betrakta som marknadskommunikation enligt tillämpliga lagar och föreskrifter. Se till så att du har läst och förstått vårt meddelande om icke-oberoende investeringsforskning och riskvarning om ovannämnda information, som finns här.

Vi använder cookies för att ge dig den bästa upplevelsen på vår webbplats. Läs mer eller ändra dina cookie-inställningar.

Riskvarning: Ditt kapital riskeras. Produkter med hävstång är inte lämpliga för alla. Vänligen se vår Riskinformation.